Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion type Assertion NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_head.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_provenance.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion evidence source_evidence_literature NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_provenance.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion SIO_000772 22850114 NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_provenance.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion wasDerivedFrom befree-20140225 NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_provenance.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion wasGeneratedBy ECO_0000203 NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_provenance.